Drug Profile
Research programme: BACE1 protein inhibitors - Medivir AB
Alternative Names: Alzheimer's disease protease inhibitors - Medivir ABLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Medivir AB
- Class
- Mechanism of Action BACE1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for research development in Alzheimer's-disease in Sweden
- 27 Jun 2008 Research and compound optimisation is ongoing for Alzheimer's disease in Sweden
- 08 Nov 2004 Early research in Alzheimer's disease in Sweden (unspecified route)